Expression of the human major vault protein LRP in human lung cancer samples and normal lung tissues

Annals of Oncology

Volumn 7, Issue 6, 1996, Pages 625-630

  Dingemans, A M C ^a   Van Ark Otte, J ^a   Van Der Valk, P ^a   Apolinario, R M ^a   Scheper, R J ^a   Postmus, P E ^a   Giaccone, G ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Detoxification; Immunohistochemistry; LRP; Lung cancer; MRP; Multidrug resistance

Indexed keywords

LUNG RESISTANCE PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; SMOKING HABIT;

EID: 0029818849     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.annonc.a010681     Document Type: Article

References (26)

1. Lai S-L, Goldstein LJ, Gottesman MM et al. MDR1 gene expression in lung cancer. J Natl Cancer Inst 1989; 81: 1144-50.
2. Goldstein LJ, Galski H, Fojo A et al. Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst 1989; 81: 116-23.
3. r 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. Cancer Res 1993; 53: 1475-9.
4. Kedersha NL, Rome LH. Isolation and characterization of a novel ribonucleoprotein particle: Large structures contain a single species of small RNA. J Cell Biol 1986; 103: 699-709.
5. Rome L, Kedersha N, Chugani D. Unlocking vaults: Organelles in search of a function. Trends Cell Biol 1991; 1: 47-50.
6. Scheffer GL, Wijngaard PLJ, Flens MJ et al. The drug resistance-related protein LRP is the human major vault protein. Nature Med 1995; 1: 578-82.
7. Izquierdo MA, Shoemaker RH, Flens MJ et al. Overlapping phenotypes of multidrug resistance among panels of human cancer-cell lines. Int J Cancer 1996; 65: 1-8.
8. Izquierdo MA, van der Zee AGJ, Vermorken JB et al. Drug resistance-associated marker LRP for prediction of response to chemotherapy and prognosis in advanced ovarian carcinoma. J Natl Cancer Inst 1995; 87: 1230-7.
9. List AF, Spier CS, Grogan TM et al. Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemia. Blood 1996; 87: 2464-9.
10. Izquierdo MA, Scheffer GL, Flens MJ et al. Broad distribution of the multidrug resistance-related vault lung resistance protein in normal human tissues and tumors. Am J Pathol 1996; 148: 877-87.
11. Slovak ML, Pelkey Ho J, Cole SPC et al. The LRP gene encoding a major vault protein associated with drug resistance maps proximal to MRP on chromosome 16: Evidence that chromosome breakage plays a key role in MRP or LRP gene amplification. Cancer Res 1995; 55: 4214-9.
12. World Health Organization. WHO Handbook for Reporting the Results of Cancer Treatment. Geneva: WHO Offset Publication 1979; 48: 1-35.
13. Flens MJ, Izquierdo MA, Scheffer GL et al. Immunochemical detection of the multidrug resistance-associated protein MRP in human multidrug-resistant tumor cells by monoclonal antibodies. Cancer Res 1994; 54: 4557-63.
14. Zaman GJR, Versantvoort CHM, Smit JJM et al. Analysis of the expresssion of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines. Cancer Res 1993; 53: 1747-50.
15. Kaplan EL. Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
16. Mantel N. Evaluation of survival data and two new rank order statistics arising in its considerations. Cancer Chemother Rep 1966; 50: 163-70.
17. Kedersha NL, Miquel M-C, Bittner D et al. Vaults. II. Ribonucleoprotein structures are highly conserved among higher and lower eukaryotes. J Cell Biol 1990; 110: 895-901.
18. Chugani D, Rome L, Kedersha N. Evidence that vault ribonucleoprotein particles localize to the nuclear pore complex. J Cell Science 1993; 106: 23-9.
19. Schuurhuis GJ, Broxterman HJ, De Lange JHM et al. Early multidrug resistance, defined by changes in intracellular doxorubicin distribution, independent of P-glycoprotein. Br J Cancer 1991; 64: 857-861.
20. Pinedo HM, Giaccone G. P-glycoprotein - a marker of cancer-cell behavior. N Engl J Med 1995; 333: 1417-9.
21. Schadendorf D, Makki A, Stahr C et al. Membrane transport proteins associated with drug resistance expressed in human melanoma. Am J Pathol 1995; 147: 1545-52.
22. Giaccone G, Van Ark-Otte J, Rubio GJ et al. MRP is frequently expressed in human lung cancer cell lines, in non-small cell lung cancer and normal lung. Int J Cancer 1996; 66: 760-7.
23. Ota E, Abe Y, Oshika Y et al. Expression of the multidrug resistance-associated protein (MRP) gene in non-small-cell lung cancer. Br J Cancer 1995; 72: 550-4.
24. Giaccone G, Gazdar AF, Beck H et al. Multidrug sensitivity phenotype of human lung cancer cells associated with topoisomerase II expression. Cancer Res 1992; 52: 1666-74.
25. Nakagawa K, Yokota J, Wada M et al. Levels of glutathione S transferase mRNA in human lung cancer cell lines correlate with the resistance to cisplatin and carboplatin. Jpn J Cancer Res 1988; 79: 301-4.
26. Cole SPC, Downes HF, Mirski SEL et al. Alteration in glutathione and glutathione-related enzymes in a multidrug-resistant small cell lung cancer cell line. Mol Pharmacol 1990; 37: 192-7.